These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 17972525)

  • 21. Acute skin toxicity following stereotactic body radiation therapy for stage I non-small-cell lung cancer: who's at risk?
    Hoppe BS; Laser B; Kowalski AV; Fontenla SC; Pena-Greenberg E; Yorke ED; Lovelock DM; Hunt MA; Rosenzweig KE
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1283-6. PubMed ID: 19028267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stereotactic Body Radiation Therapy (SBRT) for lung metastases.
    Okunieff P; Petersen AL; Philip A; Milano MT; Katz AW; Boros L; Schell MC
    Acta Oncol; 2006; 45(7):808-17. PubMed ID: 16982544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quality of life after stereotactic radiotherapy for stage I non-small-cell lung cancer.
    van der Voort van Zyp NC; Prévost JB; van der Holt B; Braat C; van Klaveren RJ; Pattynama PM; Levendag PC; Nuyttens JJ
    Int J Radiat Oncol Biol Phys; 2010 May; 77(1):31-7. PubMed ID: 19864077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stereotactic radiosurgery for the treatment of stage I non-small cell lung cancer in high-risk patients.
    Pennathur A; Luketich JD; Heron DE; Abbas G; Burton S; Chen M; Gooding WE; Ozhasoglu C; Landreneau RJ; Christie NA
    J Thorac Cardiovasc Surg; 2009 Mar; 137(3):597-604. PubMed ID: 19258073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases.
    Rusthoven KE; Kavanagh BD; Burri SH; Chen C; Cardenes H; Chidel MA; Pugh TJ; Kane M; Gaspar LE; Schefter TE
    J Clin Oncol; 2009 Apr; 27(10):1579-84. PubMed ID: 19255320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early results of CyberKnife image-guided robotic stereotactic radiosurgery for treatment of lung tumors.
    Brown WT; Wu X; Wen BC; Fowler JF; Fayad F; Amendola BE; García S; De La Zerda A; Huang Z; Schwade JG
    Comput Aided Surg; 2007 Sep; 12(5):253-61. PubMed ID: 17957532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involved-field radiotherapy is effective for patients 70 years old or more with early stage non-small cell lung cancer.
    Yu HM; Liu YF; Yu JM; Liu J; Zhao Y; Hou M
    Radiother Oncol; 2008 Apr; 87(1):29-34. PubMed ID: 18237795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of stage I non-small cell lung cancer with CyberKnife, image-guided robotic stereotactic radiosurgery.
    Ahn SH; Han MS; Yoon JH; Jeon SY; Kim CH; Yoo HJ; Lee JC
    Oncol Rep; 2009 Mar; 21(3):693-6. PubMed ID: 19212628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Baseline pulmonary function as a predictor for survival and decline in pulmonary function over time in patients undergoing stereotactic body radiotherapy for the treatment of stage I non-small-cell lung cancer.
    Henderson M; McGarry R; Yiannoutsos C; Fakiris A; Hoopes D; Williams M; Timmerman R
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):404-9. PubMed ID: 18394819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Local control of metastatic lung tumors treated with SBRT of 48 Gy in four fractions: in comparison with primary lung cancer.
    Hamamoto Y; Kataoka M; Yamashita M; Shinkai T; Kubo Y; Sugawara Y; Inoue T; Sakai S; Aono S; Takahashi T; Semba T; Uwatsu K
    Jpn J Clin Oncol; 2010 Feb; 40(2):125-9. PubMed ID: 19825814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brachial plexopathy from stereotactic body radiotherapy in early-stage NSCLC: dose-limiting toxicity in apical tumor sites.
    Forquer JA; Fakiris AJ; Timmerman RD; Lo SS; Perkins SM; McGarry RC; Johnstone PA
    Radiother Oncol; 2009 Dec; 93(3):408-13. PubMed ID: 19454366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stereotactic body radiation therapy using three fractions for isolated lung recurrence from colorectal cancer.
    Kim MS; Yoo SY; Cho CK; Yoo HJ; Choi CW; Seo YS; Kang JK; Lee DH; Hwang DY; Moon SM; Kim MS; Kang HJ; Kim YH
    Oncology; 2009; 76(3):212-9. PubMed ID: 19218825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aggravation of dyspnea in stage I non-small cell lung cancer patients following stereotactic body radiotherapy: Is there a dose-volume dependency?
    Paludan M; Traberg Hansen A; Petersen J; Grau C; Høyer M
    Acta Oncol; 2006; 45(7):818-22. PubMed ID: 16982545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stereotactic body radiation therapy for stage I non-small cell lung cancer.
    Chang JY; Roth JA
    Thorac Surg Clin; 2007 May; 17(2):251-9. PubMed ID: 17626403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dose-individualized stereotactic body radiotherapy for T1-3N0 non-small cell lung cancer: long-term results and efficacy of adjuvant chemotherapy.
    Chen Y; Guo W; Lu Y; Zou B
    Radiother Oncol; 2008 Sep; 88(3):351-8. PubMed ID: 18722684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiosurgery/stereotactic radiotherapy in the therapeutical concept for skull base meningiomas.
    Hamm K; Henzel M; Gross MW; Surber G; Kleinert G; Engenhart-Cabillic R
    Zentralbl Neurochir; 2008 Feb; 69(1):14-21. PubMed ID: 18393160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stereotactic radiosurgery for the treatment of lung neoplasm: experience in 100 consecutive patients.
    Pennathur A; Luketich JD; Heron DE; Schuchert MJ; Burton S; Abbas G; Gooding WE; Ferson PF; Ozhasoglu C; Gilbert S; Landreneau RJ; Christie NA
    Ann Thorac Surg; 2009 Nov; 88(5):1594-600; discussion 1600. PubMed ID: 19853118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases.
    Rusthoven KE; Kavanagh BD; Cardenes H; Stieber VW; Burri SH; Feigenberg SJ; Chidel MA; Pugh TJ; Franklin W; Kane M; Gaspar LE; Schefter TE
    J Clin Oncol; 2009 Apr; 27(10):1572-8. PubMed ID: 19255321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stereotactic body radiotherapy for localized prostate cancer: interim results of a prospective phase II clinical trial.
    King CR; Brooks JD; Gill H; Pawlicki T; Cotrutz C; Presti JC
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1043-8. PubMed ID: 18755555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcomes of stereotactic radiotherapy for a new clinical stage I lung cancer arising postpneumonectomy.
    Haasbeek CJ; Lagerwaard FJ; de Jaeger K; Slotman BJ; Senan S
    Cancer; 2009 Feb; 115(3):587-94. PubMed ID: 19130457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.